An Atlantic City, N.J., jury has socked Swiss pharmaceutical giant Roche Holding AG with another big verdict involving its potent acne medication, Accutane, this one to the tune of $25.16 million.
That’s how much the jury on Feb. 16 ordered the company to pay Andrew McCarrell, a computer technician from Birmingham, Ala., who took Accutane in his 20s and consequently developed inflammatory bowel disease, ultimately forcing him to have his colon removed. Accutane was made by the company’s Hoffmann-La Roche unit in Nutley, N.J., before it was taken off the market this past June.
